Phlebotomy Technician Certification Exams — Phlebotomy Technician Specialist Certification Exam Review
Answer: B
A mask must be worn by the phlebotomist when drawing the sample.
In the context of droplet precautions, a mask is essential for protecting both the healthcare worker and the patient from potential transmission of infectious agents during procedures like blood glucose monitoring.
A) Shoe covers
Shoe covers are not necessary for droplet precautions, as they primarily serve to protect from contact and are more relevant in situations where there is a risk of contamination from large amounts of fluid or solid material. In this scenario, the primary concern is airborne droplets, not contamination from the floor.
B) Mask
Wearing a mask is critical under droplet precautions, as it helps prevent the inhalation of respiratory droplets that may contain pathogens. This is particularly important when performing procedures that could potentially generate droplets, making this the correct answer.
C) Gown
While gowns are important for contact precautions to prevent contamination from body fluids, they are not specifically required under droplet precautions unless there is a risk of splashing. In this case, the primary requirement is the use of a mask.
D) Goggles
Goggles are typically used for eye protection in situations where there is a risk of fluid splashes or sprays. However, under droplet precautions, the primary protective measure needed is a mask, making goggles unnecessary in this context.
Conclusion
The requirement for a mask during procedures under droplet precautions is vital for preventing the transmission of infectious agents through respiratory droplets. While other options like gowns or goggles may have their place in certain situations, they do not address the specific need for respiratory protection in this case, thereby confirming that option B is the only appropriate choice.
Answer: A
Evacuation system
The evacuation system employs interchanging multi-sample tubes, enabling a phlebotomist to draw multiple blood specimens simultaneously. This efficiency is a significant advantage in clinical settings where time and accuracy are essential.
A) Evacuation system
This option is correct as the evacuation system is designed specifically for the simultaneous collection of multiple blood specimens using multi-sample tubes. These tubes are connected to a vacuum system that allows for quick and efficient blood draws, minimizing the need for multiple punctures and streamlining the process.
B) Hypodermic and syringe system
The hypodermic and syringe system is primarily used for drawing blood with a single syringe, which does not allow for the simultaneous collection of multiple samples. This method is more time-consuming since each sample requires a separate draw, making it less efficient compared to the evacuation system.
C) Winged infusion and syringe system
While the winged infusion set can be utilized to draw blood, it typically involves using a single tube at a time. This method is often preferred for difficult veins but does not provide the efficiency of collecting multiple samples at once, as seen with the evacuation system.
D) Lancet microcollection system
The lancet microcollection system is intended for obtaining small blood samples, often used for capillary blood draws. This method does not involve multi-sample tubes and is not designed for simultaneous collection, thus making it unsuitable for the question's requirement.
Conclusion
The evacuation system is the definitive correct answer because it uniquely allows for the collection of multiple blood specimens using interchanging tubes, enhancing efficiency in phlebotomy. All other options either focus on single-sample collection methods or are designed for specific circumstances that do not permit simultaneous draws.
3. Which of the following criteria is acceptable in determining the quality of a peripheral blood smear
Answer: B
A welldefined edge
A well-defined edge is an acceptable criterion in determining the quality of a peripheral blood smear as it indicates that the smear has been prepared properly, allowing for accurate examination of the blood cells.
A) Covers a quarter of the slide
This option is incorrect because a blood smear that only covers a quarter of the slide may not provide a sufficient area for evaluating the morphology of blood cells, leading to potential diagnostic errors.
B) A welldefined edge
This option is correct as a well-defined edge signifies that the smear is appropriately spread, which is crucial for the assessment of cell distribution and morphology essential in hematological evaluations.
C) Covers the entire slide
While a smear covering the entire slide might seem beneficial, it can be problematic if the smear is too thick or uneven, which can obscure the details necessary for accurate analysis.
D) A feathered edge
A feathered edge is indeed important in a blood smear, but it is not the primary criterion for quality assessment. The presence of a feathered edge alone does not guarantee the overall quality or adequacy of the smear for diagnostic purposes.
Conclusion
The correct answer, "A welldefined edge," highlights the importance of proper smear preparation in ensuring diagnostic accuracy. Other options either fail to meet the necessary criteria for a quality smear or can lead to misinterpretation of the blood cells, underscoring why they are less acceptable in this context.
4. For a dermal puncture on an infant the maximum depth of the lancet should be
Answer: B
The maximum depth of the lancet for a dermal puncture on an infant should be 2 mm.
Using a lancet depth of 2 mm is appropriate for dermal punctures on infants to minimize the risk of injury to deeper tissues while still obtaining an adequate blood sample.
A) 3 mm
A maximum depth of 3 mm is too deep for a dermal puncture on an infant. This depth increases the risk of hitting underlying structures, which can lead to complications such as excessive bleeding or infection.
B) 2 mm
A depth of 2 mm is the recommended maximum for a dermal puncture on an infant. This depth is sufficient to collect the necessary blood sample while ensuring the safety of the procedure by avoiding damage to underlying tissues.
C) 0.30 mm
A depth of 0.30 mm is insufficient for a dermal puncture, as it may not penetrate the skin adequately to obtain a blood sample. This depth could lead to failed attempts and unnecessary discomfort for the infant.
D) 0.20 mm
A maximum depth of 0.20 mm is also inadequate for a dermal puncture. Similar to 0.30 mm, this depth would likely not reach the capillary bed, resulting in insufficient blood collection and potential repeated punctures.
Conclusion
The correct answer, 2 mm, is critical for safely performing a dermal puncture on an infant, balancing the need for an effective blood sample while minimizing the risk of complications. Options A, C, and D fail to meet the necessary standards for safety and efficacy, while Option A exceeds the recommended depth, posing unnecessary risks.
5. Which of following is a phlebotomist required to document on a CBC specimen label?
Answer: D
Patient's identification number
A phlebotomist is required to document the patient's identification number on a CBC specimen label to ensure accurate identification and tracking of the sample throughout the testing process.
A) Patient's insurance provider name
While insurance information is important for billing and administrative purposes, it is not required on a CBC specimen label. The focus of the label is on identifying the patient and ensuring the correct sample is associated with the right individual.
B) Phlebotomist's full name
The phlebotomist's full name is generally not required on the specimen label. Instead, the emphasis is placed on patient identification to maintain the integrity of the sample and the testing process.
C) Phlebotomist's certification number
Although the phlebotomist's certification number may be relevant for compliance and quality assurance, it is not necessary to include it on a CBC specimen label. The primary goal is to document information that directly pertains to the patient and the sample.
D) Patient's identification number
Documenting the patient's identification number is crucial as it ensures that laboratory results are accurately matched to the correct patient. This practice is essential for maintaining proper records and avoiding errors in diagnosis or treatment.
Conclusion
The requirement to document the patient's identification number on a CBC specimen label is fundamental for ensuring the accuracy and reliability of laboratory results. All other options, while potentially useful in different contexts, do not fulfill the primary objective of identifying the patient associated with the specimen. Thus, option D is the only correct choice that aligns with the critical needs of specimen labeling.
6. Which of the following should a phlebotomist anticipate for a patient who has been taking warfarin?
Answer: C
Increased bleeding time
Patients taking warfarin should be anticipated to have an increased bleeding time due to the anticoagulant effects of the medication, which inhibits blood clotting.
A) Fasting requirement
There is no direct relationship between warfarin and fasting requirements. Fasting is generally not necessary for patients on warfarin unless specified for a particular test, making this option incorrect in the context of the question.
B) Alternate antiseptic required
While certain antiseptics may be preferred in specific situations, there is no indication that a phlebotomist would need to use an alternate antiseptic specifically for patients on warfarin. This option does not address the primary concern related to the effects of the medication.
C) Increased bleeding time
This option is correct because warfarin is an anticoagulant that prolongs the time it takes for blood to clot, leading to increased bleeding time. Phlebotomists must be particularly cautious when performing venipuncture on patients taking warfarin to minimize the risk of excessive bleeding.
D) Specimen placed on ice
Placing a specimen on ice is typically not a standard requirement for patients on warfarin. This procedure is more relevant for tests that require temperature control, such as certain hormone levels or metabolic panels, making this option incorrect.
Conclusion
The correct answer is "Increased bleeding time" as it directly correlates with the anticoagulant properties of warfarin, significantly affecting the patient’s bleeding risk during blood draws. All other options do not address the specific considerations a phlebotomist must take into account when dealing with a patient on warfarin, making them unsuitable in this context.
Answer: A
The specimen temperature should be taken before 4 minutes after collection.
To ensure the integrity of the urine drug screen, the phlebotomist must measure the specimen temperature before 4 minutes have elapsed since collection, as this is crucial for verifying that the sample is fresh and has not been tampered with.
A) Before 4 min
This option is correct because measuring the temperature within the first 4 minutes is essential for confirming that the specimen is within the acceptable temperature range, indicating that it is likely a valid sample.
B) At 5 min
This option is incorrect because waiting until 5 minutes has passed may result in a temperature reading that is no longer valid. The guidelines specify taking the temperature before reaching this time frame to ensure accuracy.
C) At 15 min
This option is incorrect as well, since taking the temperature at 15 minutes exceeds the recommended time limit. By this point, the urine may have cooled down significantly, raising doubts about its validity as a fresh sample.
D) After 30 min
This option is also incorrect, as measuring the temperature after 30 minutes is far beyond the acceptable window. At this stage, the sample is unlikely to reflect the actual body temperature, which is critical for determining the sample's authenticity.
Conclusion
The correct answer, measuring the specimen temperature before 4 minutes, is vital for maintaining the integrity of the urine drug screen. Other options fail because they either exceed the recommended timeframe or compromise the validity of the sample, ultimately undermining the testing process.
Answer: A
A phlebotomist should verify that a patient has fasted for 8 to 12 hours prior to obtaining a fasting specimen.
This fasting duration is essential to ensure accurate laboratory results, particularly for tests that may be influenced by recent food intake.
A) 8 to 12 hr
This option is correct as fasting for 8 to 12 hours is the standard requirement before obtaining a fasting specimen. This time frame allows for the metabolism of food and ensures that the test results are not affected by recent dietary intake.
B) 1 to 2 hr
This option is incorrect because a fasting period of only 1 to 2 hours is insufficient for most laboratory tests. This duration does not allow enough time for the body to process and clear nutrients from recent meals, potentially leading to misleading test results.
C) 4 to 6 hr
This option is also incorrect, as a fasting period of 4 to 6 hours is typically too short to achieve the necessary metabolic state required for accurate fasting test results. Many tests specifically require a longer fasting duration to ensure reliability.
D) 24 hr
This option is incorrect because fasting for 24 hours exceeds the standard requirements for fasting specimens. While some specialized tests may require extended fasting, the general standard for routine fasting tests is 8 to 12 hours, making 24 hours unnecessary and potentially harmful.
Conclusion
The correct answer is 8 to 12 hours, which is the accepted fasting duration necessary for reliable laboratory results in fasting specimens. All other options fail to meet the standard fasting requirements, either being too short or excessively long, and therefore would compromise the accuracy of the test outcomes.
9. Which of the following tube additives promotes clot formation
Answer: D
Silica promotes clot formation.
Silica is a tube additive that promotes clot formation by activating the coagulation cascade. It is commonly used in serum separator tubes to facilitate the collection of serum for laboratory tests.
A) Heparin
Heparin is an anticoagulant that prevents clot formation by inhibiting thrombin and factor Xa. Therefore, it does not promote clot formation but rather works to keep blood in a liquid state, making it incorrect in the context of the question.
B) Oxalate
Oxalate acts as an anticoagulant by binding calcium ions, which are necessary for the clotting process. This means that oxalate inhibits clot formation, making it an incorrect choice for promoting clotting.
C) Citrate
Citrate also functions as an anticoagulant by chelating calcium ions, thereby preventing the clotting cascade from occurring. Because of this mechanism, citrate does not promote clot formation and is therefore not the correct answer.
D) Silica
Silica is specifically known for its ability to promote clot formation by serving as a surface that activates platelets and encourages the coagulation process. This makes silica the correct answer as it directly facilitates the formation of clots in blood samples.
Conclusion
Silica is the only option among the choices that actively promotes clot formation, while heparin, oxalate, and citrate serve to inhibit this process. Understanding the role of these additives is crucial in laboratory settings, particularly when collecting blood samples for testing that require serum. Thus, silica is definitively the correct answer.
Answer: D
Maintain an open airway.
Ensuring that the patient has an open airway is crucial in cases of shock, as it allows for adequate oxygenation and ventilation. This first aid measure is essential for stabilizing the patient's condition and preventing further complications.
A) Keep the patient as upright as possible.
This option is incorrect because keeping a patient upright can exacerbate the situation in cases of shock. It is generally recommended to lay the patient down and elevate their legs to promote blood flow to vital organs.
B) Provide a cooling blanket.
Providing a cooling blanket is not appropriate in this scenario as it does not address the immediate needs of a patient in shock. The priority should be to maintain the patient's airway and ensure they receive adequate oxygen rather than focusing on temperature regulation.
C) Administer oral fluids.
Administering oral fluids is not advisable in cases of shock, especially if the patient is not conscious or is unable to swallow. The priority should be to maintain an open airway and provide intravenous fluids under medical supervision if necessary.
D) Maintain an open airway.
This option is correct as maintaining an open airway is vital for any patient in shock. It ensures that the patient can breathe adequately and receive oxygen, which is critical for their survival and recovery.
Conclusion
Maintaining an open airway is the most critical first aid measure for a patient in shock, as it directly impacts oxygen delivery to the body. Other options either fail to address the immediate needs of the patient or could potentially worsen their condition. Therefore, ensuring an open airway is the definitive first step in managing a severe medication reaction leading to shock.